Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

ALMASIO, Pier Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.173
EU - Europa 6.898
AS - Asia 4.824
SA - Sud America 696
AF - Africa 139
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 25.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.034
RU - Federazione Russa 2.051
SG - Singapore 1.724
CN - Cina 1.346
DE - Germania 1.135
IT - Italia 1.126
BR - Brasile 570
FI - Finlandia 552
UA - Ucraina 541
HK - Hong Kong 540
VN - Vietnam 371
IE - Irlanda 310
PL - Polonia 297
GB - Regno Unito 270
FR - Francia 221
JP - Giappone 173
SE - Svezia 135
KR - Corea 133
BD - Bangladesh 110
IN - India 85
TR - Turchia 71
MX - Messico 60
RO - Romania 56
CA - Canada 54
AR - Argentina 49
IQ - Iraq 49
BE - Belgio 42
NL - Olanda 33
AT - Austria 32
CI - Costa d'Avorio 32
UZ - Uzbekistan 25
PK - Pakistan 23
ZA - Sudafrica 20
KE - Kenya 18
EG - Egitto 17
ID - Indonesia 17
IR - Iran 17
ES - Italia 16
VE - Venezuela 16
PH - Filippine 15
EC - Ecuador 14
MA - Marocco 14
CO - Colombia 13
CZ - Repubblica Ceca 13
MY - Malesia 13
NP - Nepal 12
SA - Arabia Saudita 12
BG - Bulgaria 11
TN - Tunisia 11
CL - Cile 10
DZ - Algeria 10
GR - Grecia 10
CH - Svizzera 9
JO - Giordania 9
AM - Armenia 8
LB - Libano 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
AZ - Azerbaigian 7
DK - Danimarca 7
KG - Kirghizistan 7
PE - Perù 7
UY - Uruguay 7
JM - Giamaica 6
LT - Lituania 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
AL - Albania 5
GE - Georgia 5
KZ - Kazakistan 5
PY - Paraguay 5
ET - Etiopia 4
EU - Europa 4
HU - Ungheria 4
IL - Israele 4
OM - Oman 4
PS - Palestinian Territory 4
PT - Portogallo 4
BO - Bolivia 3
GA - Gabon 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GY - Guiana 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
Totale 25.729
Salva come PNG Salva come JPEG
Città #
Fairfield 1.700
Ashburn 1.422
Singapore 1.192
Woodbridge 936
Houston 915
Chandler 660
Seattle 652
Wilmington 651
Cambridge 584
San Jose 559
Hong Kong 509
Ann Arbor 438
Secaucus 340
Cologne 325
Dublin 308
Jacksonville 279
Zgierz 267
Moscow 254
Palermo 230
Medford 220
Los Angeles 197
Beijing 181
Council Bluffs 172
Santa Clara 164
Des Moines 162
Tokyo 157
Nanjing 147
Altamura 137
Princeton 135
Frankfurt am Main 132
Ho Chi Minh City 124
Lauterbourg 118
Lawrence 118
Milan 115
New York 113
Hanoi 107
Boardman 105
Hefei 103
San Diego 101
Dallas 88
Dearborn 82
Helsinki 77
Chicago 76
Tulsa 76
Shenyang 62
São Paulo 61
The Dalles 61
Jinan 59
Nanchang 54
Buffalo 50
London 47
Changsha 45
Phoenix 45
Ludwigshafen am Rhein 43
Brussels 40
Seongnam 40
Hebei 38
Orem 36
Tianjin 35
Jiaxing 34
Columbus 33
Abidjan 31
San Paolo di Civitate 31
Izmir 30
Ningbo 30
Seoul 29
Venice 28
Atlanta 27
Saint Petersburg 27
Guangzhou 26
Baghdad 23
Berlin 22
Falls Church 22
Nuremberg 21
Amsterdam 20
Verona 20
Zhengzhou 20
Haiphong 19
Auburn Hills 18
Lanzhou 18
Rome 18
Brooklyn 17
Denver 17
San Mateo 17
Taiyuan 17
Warsaw 17
Hangzhou 16
Mumbai 16
Nairobi 16
Tashkent 16
Boston 15
Brasília 15
Chennai 15
Porto Alegre 15
Ankara 14
Curitiba 14
Kumar 14
Mexico City 14
Rio de Janeiro 14
Stockholm 14
Totale 16.984
Salva come PNG Salva come JPEG
Nome #
12 weeks of interferon-based therapy is feasible in patients with hepatitis C-related cirrhosis and thrombocytopenia: A post hoc analysis of eltrombopag studies 1.318
The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection. 377
A functional study of the esophagus in patients with non-cardiac chest pain and dysphagia 331
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b 326
HCV genotypes in Sicily: is there any evidence of a shift? 310
Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial. 304
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort 299
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 295
Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction 295
B lymphocyte intestinal homing in inflammatory bowel disease. 292
Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol 284
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 282
Characteristics of liver cirrhosis in Italy: results from a multicenter national study 280
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology 272
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. 270
Esophageal motility changes after thyroidectomy; possible associations with postoperative voice and swallowing disorders: preliminary results. 268
Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. 265
Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. 265
Pegylated-interferon-α(2a) in clinical practice: how to manage patients suffering from side effects 262
Esophageal motility changes after thyroidectomy: possible associations with postoperative voice and swallowing disorders 260
Long-term manometric study of anal sphincter function after hemorrhoidectomy. 259
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 253
Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases 249
Improvement of wound healing after hemorrhoidectomy: a double-blind, randomized study of botulinum toxin injection 246
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study. 246
Impact of hepatitis C virus infection on lifestyle. 243
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 242
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial 240
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 238
Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study*. 228
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 228
Granular cell tumor of stomach: a case report and review of literature. 226
Chronic hepatitis C infection and insulin resistance: two best friends. 226
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance 226
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis 221
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. 219
STORIA NATURALE DELLA CIRROSI EPATICA 217
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions. 217
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD 216
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 215
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 214
Interaction of alcohol intake and cofactors on the risk of cirrhosis. 214
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C 213
PROSPECTIVE, RANDOMIZED, CROSSOVER COMPARISON OF SUBLINGUAL APOMORPHINE (3 mg) WITH ORAL SILDENAFIL (50 mg) FOR MALE ERECTILE DYSFUNCTION 212
A woman with a long history of abdominal pain 212
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 210
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome 206
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy 206
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial 204
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy 200
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. 197
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine 196
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study 195
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. 193
Kinetic analysis of insulin resistance and serum adipocytokines levels during peginterferon alpha-2A plus ribavirin therapy in non-diabetic HCV patients 191
Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study 189
HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey. 188
CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY 188
Management of hepatitis B virus infection in the underprivileged world. 188
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction 188
Pharmacological Treatment of Patients with Chronic Critical Limb Ischemia: L-Propionyl-Carnitine Enhances the Short-Term Effects of PGE-1 185
Current practice of hepatitis C treatment in Southern Italy. 181
Management of hepatitis C virus genotype 4: recommendations of an international expert panel. 180
Weight-based dosing: which impact on efficacy and safety of therapy? 179
Necrotizing Soft Tissue Fasciitis after Intramuscular Injection 179
Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens. 178
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. 177
New therapeutic prospects in HCV treatment. 177
Unusual B cell morphology in inflammatory bowel disease. 177
Impact of comorbidities on the severity of chronic hepatitis B at presentation. 176
Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs 175
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study 174
HCV genotypes in western Sicily: any evidence for a shift? 173
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. 173
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 172
DISTRIBUTION OF ESOPHAGEAL DYSMOTILITIES AMONG PATIENTS WITH NON-CARDIAC CHEST PAIN, DYSPHAGIA OR BOTH 171
The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing 170
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). 168
Small bowel angiodysplasia associated with von Willebrand's disease: report of a case 168
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases 165
Trends of aetiological factors of hepatocellular carcinoma in Italy 164
Meccanismi immunologici e molecolari del danno epatico da farmaci 161
Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study 160
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 158
Liver function test abnormalities in patients with inflammatory bowel diseases: A hospital-based survey 158
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy 157
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication 157
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. 153
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response 153
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study 152
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. 151
Current practice of chronic hepatitis B treatment in Southern Italy. 151
Experts' opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.) 150
Recurrent sacrococcygeal pilonidal disease: the efficacy of minimal subcutaneous excision of the sinus and unroofing of pseudocystic cavity 150
Epidemiology and clinical course of drug-induced liver injury 146
Inguinal hernioplasty improves the quality of life in patients with cirrhosis. 143
Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. 143
Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. 143
IL-10 and TNF-α polymorphisms and the recovery from HCV infection 143
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response 142
Totale 22.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.603
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021202 0 0 0 0 0 0 0 0 0 0 0 202
2021/20221.637 70 379 35 50 54 71 104 72 216 195 120 271
2022/20232.038 214 416 31 201 256 316 121 135 217 13 69 49
2023/2024830 55 120 46 45 56 156 84 37 64 35 17 115
2024/20252.241 58 120 98 214 82 87 167 175 137 246 251 606
2025/20269.515 496 528 417 888 818 1.208 1.480 787 1.281 1.119 421 72
Totale 26.254